Auditory hypersensitivity, or hyperacusis, is characterized by increased sensitivity to sound and is often associated with tinnitus, yet its underlying mechanisms remain unclear. This study investigated the mechanisms of sodium salicylate-induced auditory hypersensitivity in mice, focusing on neuroinflammation, microglial activation, and neuronal excitability....
No actionable change for clinical practice yet — findings are from a mouse model only and require replication in human trials before informing hyperacusis treatment.
Identifying GABAergic pathways as a modulator of hyperacusis and auditory neuroinflammation opens a potential therapeutic target for patients with debilitating sound sensitivity.
- 01Sodium salicylate-treated mice showed auditory hypersensitivity (hyperacusis) and neuroinflammation.
- 02GABAergic modulation significantly reduced both hypersensitivity and neuroinflammatory markers.
- 03Study is limited to male mice; sex differences and human applicability are unknown.
- 04GABA-targeting drugs are already used clinically, making translational research feasible.
- 05Published in Neuroscience; preclinical animal study only.
GABAergic modulation reduces auditory hypersensitivity induced by sodium salicylate in mice.
studysupportedGABAergic modulation alleviates neuroinflammation in sodium salicylate-treated mice.
studysupportedSodium salicylate induces auditory hypersensitivity and neuroinflammation in male mice.
studysupported- PMID
- 42086103
- DOI
- 10.1016/j.neuroscience.2026.04.035.
- Journal
- Neuroscience
- Publication type
- research_article
- Evidence level
- 4
- Population
- Male mice treated with sodium salicylate
- Intervention
- GABAergic modulation
- Comparator
- Untreated or vehicle-treated mice
Primary outcomes
Auditory hypersensitivity (hyperacusis) measures; Neuroinflammation markers in auditory system